News

Velos, Inc., the resource for clinical trial management information systems for large investigator sites, today announced it will cross the 50 percent market penetration threshold by year end.

Sparta Systems, Inc., a provider of compliance management software, today announced that the leading global provider of innovative home and long-term care medical products, Invacare Corporation, selected Sparta?s TrackWise Quality Management Solution (QMS).

The Academy of Pharmaceutical Physicians and Investigators (APPI), a nonprofit group of nearly 1,200 physician members involved in the clinical research enterprise, has joined the Clinical Trials Transformation Initiative (CTTI).

Phase Forward (NASDAQ: PFWD), a provider of data management solutions for clinical trials and drug safety, today announced a multi-year extension agreement with Eli Lilly and Company (NYSE: LLY).

Clinilabs, Inc., a specialty contract research organization (CRO), has completed expansion of its Phase I unit.

Covance Inc. (NYSE:CVD), a leading provider of drug development services, announced today that it signed a definitive agreement with Eli Lilly and Company (NYSE: LLY) to help transform Lilly's R&D model.

Dr. LingSing K. Chen has been chosen to head the new Translational Medicine department at QPS, a provider of research services for the pharmaceutical industry.

Abingdon Life Sciences, Inc. has entered into an agreement with Stason Pharmaceuticals, Inc to provide clinical and regulatory support for Stason?s drug development programs.

Medidata Solutions, a provider of clinical trial solutions, today announced that Taiho Pharmaceutical Co., Ltd. will implement Medidata Rave as its electronic data capture (EDC), management and reporting solution of choice.

Clinilabs, Inc., a specialty contract research organization (CRO), is now a Mortara Certified Partner capable of collecting, processing, and transmitting annotated ECG data compliant with ECG Warehouse requirements.

CEO Chairman Jim Walker of Octagon Research Solutions, Inc., a provider of breakthrough software and services to the life sciences industry, today announced that Summit Drug Development Services, LLC has chosen both ViewPoint and StartingPoint to facilitate submission document authoring and integrated electronic regulatory submission management.

PAREXEL International Corporation (NASDAQ: PRXL), a global biopharmaceutical services organization, today provided an update with regard to the previously announced proposal whereby an indirect wholly owned subsidiary of PAREXEL will acquire the entire issued and to be issued ordinary share capital of ClinPhone plc, a company traded on the London Stock Exchange.

With the option to rent, the buy vs. build debate over software is kaput when it comes to major applications.

The story of two very different companies' transition to electronic.